Alnylam Pharmaceuticals
Roman To, CPA, ACCA, currently serves as Director and Assistant Controller at Alnylam Pharmaceuticals since January 2024, and has been a Young Partner (Volunteer) at Social Venture Partners Boston since December 2021, focusing on community investment in nonprofits. Prior experience includes roles as Corporate Controller at Great Elm Capital Management, Inc., and Associate Director/Experienced Managing Consultant at CrossCountry Consulting. Roman To also spent nearly a decade at EY, where the role of Audit Manager involved overseeing audits for major clients in accordance with IFRS and US GAAP. Roman To holds a Master of Economics in Finance from Novosibirsk State University, obtained between 2009 and 2011.
Alnylam Pharmaceuticals
32 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.